Skip to content
value.today
TransMedics, Inc. logo

TransMedics, Inc.

Total raised
$161 M
5 rounds on record
Latest round
$64 M
May 2016
First round on record
Feb 2010
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of TransMedics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2016$64 MNo. 5$50 to $250 million

TransMedics, Inc.: Raise no. 5, May 2016

Investors in this round

20 investors had bought by the notice of Jul 12, 2016: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$64 M of $64 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stephen R. Gordon · Executive Officer
  • Waleed H. Hassanein · Executive Officer, Director
  • David R. Abrams · Director
  • Dmitry R. Kobyzev · Director
  • Edward R. Basile · Director
  • Edwin M. Kania, Jr. · Director
  • James R. Gilbert · Director
  • James R. Tobin · Director
  • Travis R. Rhodes · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Gordon, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 12, 2016. Read the notice at the SEC.

equitySEC
May 2015$20 MNo. 4$10 to $50 million

TransMedics, Inc.: Raise no. 4, May 2015

Investors in this round

11 investors had bought by the notice of Jun 4, 2015: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stephen Lee Gordon · Executive Officer
  • Waleed H. Hassanein · Executive Officer, Director
  • David Lee Abrams · Director
  • Earl M. Collier, Jr. · Director
  • Edwin M. Kania, Jr. · Director
  • James R. Tobin · Director
  • Joseph S. Lacob · Director
  • Kenneth M. Bate · Director
  • Tony Lee White · Director
  • Travis Lee Rhodes · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Gordon, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 4, 2015. Read the notice at the SEC.

equitySEC
Nov 2012$36 MNo. 3$10 to $50 million

TransMedics, Inc.: Raise no. 3, Nov 2012

Investors in this round

15 investors had bought by the notice of Nov 21, 2012: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$36 M of $36 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$425,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Domenic Lee Micale · Executive Officer
  • Waleed H. Hassanein · Executive Officer, Director
  • David Lee Abram · Director
  • Earl M. Collier · Director
  • Edwin M. Kania, Jr. · Director
  • James M. Tobin · Director
  • Joseph M. Lacob · Director
  • Kenneth M. Bate · Director
  • Tony Lee White · Director
  • Travis Lee Rhodes · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Piper Jaffray & Co. (CRD 665) · broker-dealer Piper Jaffray & Co. (CRD 665) · Minneapolis, MinnesotaSold in MA

Signed by Domenic Micale, Vice President of Finance. Source: SEC Form D, newest notice filed Nov 21, 2012. Read the notice at the SEC.

equity, optionsSEC
Aug 2011$6 MNo. 2$2 to $10 million

TransMedics, Inc.: Raise no. 2, Aug 2011

Investors in this round

9 investors had bought by the notice of Aug 15, 2011: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $23 M offered; $17 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Domenic M. Micale · Executive Officer
  • Waleed H. Hassanein · Executive Officer, Director
  • Earl M. Collier · Director
  • Edwin M. Kania, Jr. · Director
  • James M. Tobin · Director
  • Joseph M. Lacob · Director
  • Kenneth M. Bate · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Domenic Micale, Vice President of Finance. Source: SEC Form D, newest notice filed Aug 15, 2011. Read the notice at the SEC.

equitySEC
Feb 2010$35 MNo. 1$10 to $50 million

TransMedics, Inc.: Raise no. 1, Feb 2010

Investors in this round

26 investors had bought by the notice of Mar 1, 2010: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$35 M of $35 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Waleed H. Hassanein · Executive Officer, Director
  • Adam M. Grosser · Director
  • Edwin M. Kania, Jr. · Director
  • Joseph M. Lacob · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total amount sold includes approximately $9 million worth of equity issued from converted debt.”

Signed by Waleed H. Hassanein, President and CEO. Source: SEC Form D, newest notice filed Mar 1, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • TransMedics, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2016).

    SEC Form D · Jul 2016

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2016

That is all the official record says: TransMedics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.

Investors#

No investor of TransMedics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 26 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by TransMedics, Inc.
NameRoleNamed in
Stephen R. GordonExecutive officerJul 2016
Waleed H. HassaneinExecutive officerJul 2016
Stephen Lee GordonExecutive officerJun 2015
Domenic Lee MicaleExecutive officerNov 2012
Domenic M. MicaleExecutive officerAug 2011
David R. AbramsDirectorJul 2016
Dmitry R. KobyzevDirectorJul 2016
Edward R. BasileDirectorJul 2016
Edwin M. Kania, Jr.DirectorJul 2016
James R. GilbertDirectorJul 2016
James R. TobinDirectorJul 2016
Travis R. RhodesDirectorJul 2016
Waleed H. HassaneinDirectorJul 2016
David Lee AbramsDirectorJun 2015
Earl M. Collier, Jr.DirectorJun 2015
Joseph S. LacobDirectorJun 2015
Kenneth M. BateDirectorJun 2015
Tony Lee WhiteDirectorJun 2015
Travis Lee RhodesDirectorJun 2015
David Lee AbramDirectorNov 2012
Earl M. CollierDirectorNov 2012
James M. TobinDirectorNov 2012
Joseph M. LacobDirectorNov 2012
Adam M. GrosserDirectorMar 2010